首页 / 技术领域 / 转基因生物 / 专利数据
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 PRODUCTION OF BIOFILAMENTS IN TRANSGENIC ANIMALS PCT/IB9900763 1999-03-12 WO9947661A3 2000-01-06 KARATZAS COSTAS N; TURNER JEFFREY D; KARATZAS ANTHOULA-LAZARIS
Disclosed is a method for the recombinant production of biofilaments, such as spider silk or insect fibroins, using transgenic animals which secrete the biofilaments in their milk and/or urine, and transgenic cells which secrete the biofilaments into culture media. Such a method is useful for producing large quantities of biofilament material. Also disclosed is a nucleic acid molecule for generating such transgenic animals.
182 PRODUCTION OF BIOFILAMENTS IN TRANSGENIC ANIMALS PCT/IB1999/000763 1999-03-12 WO99047661A2 1999-09-23
Disclosed is a method for the recombinant production of biofilaments, such as spider silk or insect fibroins, using transgenic animals which secrete the biofilaments in their milk and/or urine, and transgenic cells which secrete the biofilaments into culture media. Such a method is useful for producing large quantities of biofilament material. Also disclosed is a nucleic acid molecule for generating such transgenic animals.
183 ENGINEERING PROTEIN POSTTRANSLATIONAL MODIFICATION IN TRANSGENIC ORGANISMS PCT/US9606121 1996-05-06 WO9634966A3 1996-12-05 LUBON HENRYK; DROHAN WILLIAM N; PALEYANDA REKHA K
The invention relates to transgenic non-human multicellular organisms that contain polynucleotides for expressing proteins that alter posttranslational modification. In particular, the invention provides multiply-transgenic animals in which a first transgene encodes a first protein, a second transgene encodes a second protein, and expression of the second protein affects the posttranslational modification of the first protein in cells of said organism. Expression in preferred embodiments is in specific cells and the modified protein is secreted into a bodily fluid. The invention provides related methods, proteins and products. An example provides transgenic animals that express human Protein C and the processing protease PACE/furin in mammary glands and secrete both proteins into milk.
184 ENGINEERING PROTEIN POSTTRANSLATIONAL MODIFICATION IN TRANSGENIC ORGANISMS PCT/US1996006121 1996-05-06 WO1996034966A2 1996-11-07 AMERICAN RED CROSS; LUBON, Henryk; DROHAN, William, N.; PALEYANDA, Rekha, K.
The invention relates to transgenic non-human multicellular organisms that contain polynucleotides for expressing proteins that alter posttranslational modification. In particular, the invention provides multiply-transgenic animals in which a first transgene encodes a first protein, a second transgene encodes a second protein, and expression of the second protein affects the posttranslational modification of the first protein in cells of said organism. Expression in preferred embodiments is in specific cells and the modified protein is secreted into a bodily fluid. The invention provides related methods, proteins and products. An example provides transgenic animals that express human Protein C and the processing protease PACE/furin in mammary glands and secrete both proteins into milk.
185 TRANSGENIC BIRDS THAT PRODUCE CHIMERIC HUMAN IMMUNOGLOBULINS US15142097 2016-04-29 US20160309686A1 2016-10-27 Philip A. Leighton; Emily J. Cadera
The invention relates to transgenic birds capable of producing chimeric immunoglobulins, with a combination of human and avian sequence, in their B cells. In some embodiments, the birds are chickens. When challenged with an antigen, the transgenic avians produce antigen-specific functional antibodies. The invention also relates to light chain immunoglobulin transgenes for making such transgenic avians, as well as methods and vectors for disrupting endogenous immunoglobulin loci in birds.
186 High throughput screening of genetically modified photosynthetic organisms US12156432 2008-05-30 US08268553B2 2012-09-18 Stephen Mayfield; Bryan O'Neill; Michael Mendez; Kari Mikkelson; Yan Poon
The present invention provides a method and compositions for high throughput screening of genetically modified photosynthetic organisms for plasmic state. The present invention provides methods of producing one or more proteins, including biomass degrading enzymes in a plant. Also provided are the methods of producing biomass degradation pathways in alga cells, particularly in the chloroplast. Single enzymes or multiple enzymes may be produced by the methods disclosed. The methods disclosed herein allow for the production of biofuel, including ethanol.
187 Method of generating transgenic organisms using transposons US12655114 2009-12-23 US20110185442A1 2011-07-28 Charalambos Savakis; Frank Grosveld
The invention relates to a method for generating a transgenic organism. The invention also relates to a method for detecting and characterizing a genetic mutation in a transgenic organism. The invention further relates to a method for isolating a gene which is correlated with a phenotypic characteristic in a transgenic animal. The invention further relates to a method for isolating an exon in a transgenic animal. The invention also relates to a method for modulating the expression of a gene in an organism.
188 Transgenic organisms with lower growth temperature US10575505 2004-10-11 US07811784B2 2010-10-12 Manuel Ferrer; Kenneth Timmis; Tatjana Chernikova; Peter Golyshin; Michail Yakimov
The invention relates to the growth temperature of organisms, especially plants and microorganisms and the manipulation of the tolerable cultivation temperature. More specifically, the present invention relates to the expression of heterologous proteins in microorganisms, and especially to the heterologous expression of heat sensitive proteins in bacteria, either gram-negative or gram-positive. In a first aspect, the present invention provides a method for manipulation of cells and the resultant cells, wherein at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed. Such cells are selected among cultivated eukaryotic cells, i.e. animal and plant cells and entire plants, gram-negative and gram-positive bacteria, fungi and yeasts.
189 Process of producing environmentally safe transgenic organisms US10512879 2002-04-29 US07632981B2 2009-12-15 Stefan Werner; Sylvestre Marillonnet; Victor Klimyuk; Yuri Gleba
A process of producing a transgenic multi-cellular plant or animal organism expressing a trait of interest and having a controlled distribution of said trait to progeny, wherein said process comprises hybridising a first multi-cellular organism or a cell thereof having a first heterologous DNA sequence comprising a first fragment of a nucleotide sequence encoding said trait of interest and a second multi-cellular organism or a cell thereof having a second heterologous DNA sequence comprising a second fragment of the nucleotide sequence encoding said trait of interest, whereby said first and said second heterologous sequences are designed such that said trait of interest arises due to RNA trans-splicing after said hybridation.
190 Transgenic organisms with lower growth temperature US10575505 2004-10-11 US20090255014A1 2009-10-08 Manuel Ferrer; Kenneth Timmis; Tatjana Chernikova; Peter Golyshin; Michail Yakimov
The invention relates to the growth temperature of organisms, especially plants and microorganisms and the manipulation of the tolerable cultivation temperature. More specifically, the present invention relates to the expression of heterologous proteins in microorganisms, and especially to the heterologous expression of heat sensitive proteins in bacteria, either gram-negative or gram-positive. In a first aspect, the present invention provides a method for manipulation of cells and the resultant cells, wherein at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed. Such cells are selected among cultivated eukaryotic cells, i.e. animal and plant cells and entire plants, gram-negative and gram-positive bacteria, fungi and yeasts.
191 Method of generating transgenic organisms using transposons US10245441 2002-09-17 US20030150007A1 2003-08-07 Charalambos Savakis; Frank Grosveld
The invention relates to a method for generating a transgenic organism. The invention also relates to a method for detecting and characterizing a genetic mutation in a transgenic organism. The invention further relates to a method for isolating a gene which is correlated with a phenotypic characteristic in a transgenic animal. The invention further relates to a method for isolating an exon in a transgenic animal. The invention also relates to a method for modulating the expression of a gene in an organism.
192 Genetically engineered organisms expressing surface proteins of T. cruzi US537798 1983-09-30 US4615973A 1986-10-07 Paul Lizardi; Nadia Nogueira
Genetically engineered plasmids which express DNA encoding for insect stage specific glycoproteins of Trypanosoma cruzi are disclosed. The glycoproteins offer potential diagnostic utility for the detection of Chagus disease.
193 METHOD FOR IMPROVING TURFGRASS ABIOTIC STRESS TOLERANCE PCT/US2015/058288 2015-10-30 WO2016073301A1 2016-05-12 JAMES, John Robert; DANT, Lukas

The present invention relates to a method of controlling abiotic stress on warm-season turfgrass using an effective amount of acibenzolar- s-methyl.

194 VERFAHREN ZUR HERSTELLUNG VON MEHRFACH UNGESÄTTIGTEN FETTSÄUREN IN TRANSGENEN ORGANISMEN PCT/EP2008/052358 2008-02-27 WO2008104559A1 2008-09-04 ABBADI, Amine; FEUSSNER, Ivo; HOFFMANN, Mareike

Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren, insbesondere langkettigen mehrfach ungesättigten Fettsäuren wie Arachidonsäure und/oder Eicosapentaensäure, in einem transgenen Organismus, indem Nukleinsäuren in den Organismus eingebracht werden, die für Polypeptide mit delta-6-Desaturase-, delta-6-Elongase- und/oder delta-5-Desaturase-Aktivität kodieren. Vorteilhaft stammen die delta-6-Desaturase und die delta-5-Desaturase aus Mantoniella squamata und die delta-6-Elongase aus Physcomitrella patens. Vorteilhaft wird in dem Organismus weiterhin ein Gen, das für eine omega-3-Desaturase kodiert, exprimiert. In einer weiteren vorteilhaften Ausführungsform des Verfahrens können weitere Nukleinsäuresequenzen, die für Polypeptide der Biosynthese des Fettsäure- und Lipidstoffwechsels kodieren, in dem Organismus exprimiert werden. Besonders vorteilhaft sind hierfür die Nukleinsäuresequenzen, die für eine delta-8-Desaturase-, delta-12-Desaturase-, delta-15-Desaturase, delta-4-Desaturase, delta-9-Elongase- und/oder delta-5-Elongase-Aktivität kodieren.

195 VERFAHREN ZUR HERSTELLUNG MEHRFACH UNGESÄTTIGTER FETTSÄUREN IN TRANSGENEN ORGANISMEN PCT/EP2007/060554 2007-10-04 WO2008040787A2 2008-04-10 BAUER, Jörg; WETJEN, Tom

Die vorliegende Erfindung betrifft Polynucleotide aus Ostreococcus lucimarinus, die Desaturasen und Elongasen kodieren und zur rekombinanten Herstellung von mehrfach ungesättigten Fettsäuren eingesetzt werden können. Weiterhin betrifft die Erfindung Vektoren, Wirtszellen und transgene nicht-humane Organismen, die die Polynucleotide enthalten, sowie die von den Polynucleotiden kodierten Polypeptide. Schließlich betrifft die Erfindung noch Herstellungsverfahren für die mehrfach ungesättigten Fettsäuren und für Öl-, Lipid- und Fettsäurezusammensetzungen.

196 VERFAHREN ZUR HERSTELLUNG MEHRFACH UNGESÄTTIGTER FETTSÄUREN IN TRANSGENEN ORGANISMEN PCT/EP2005/013803 2005-12-21 WO2006069710A1 2006-07-06 CIRPUS, Petra; BAUER, Jörg; HEINZ, Ernst; DOMERGUE, Frederic

Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren in einem Organismus, indem Nukleinsäuren in den Organismus eingebracht werden, die für Polypeptide mit ?-5-Elongase-, ?-6-Desaturase-, eine ?-5-Desaturase-, ?-4-Desaturase-, ?-12-Desaturase- und/oder ?-6-Elongaseaktivität codieren. Vorteilhaft stammen diese Desaturasen und Elongasen aus Ostreococcus. Weiterhin betrifft die Erfindung ein Verfahren zur Herstellung von Ölen und/oder Triacylglyceriden mit einem erhöhten Gehalt an langkettigen mehrfach ungesättigten Fettsäuren. Die Erfindung betrifft weiterhin die Nukleinsäuresequenzen, Nukleinsäurekonstrukte, Vektoren und Organismen enthaltend die erfindungsgemässen Nukleinsäuresequenzen, Vektoren enthaltend die Nukleinsäuresequenzen und/oder die Nukleinsäurekonstrukte sowie transgene Organismen enthalten die vorgenannten Nukleinsäuresequenzen, Nukleinsäurekonstrukte und/oder Vektoren. Ein weiterer Teil der Erfindung betrifft Öle, Lipide und/oder Fettsäuren hergestellt nach dem erfindungsgemässen Verfahren und deren Verwendung. Ausserdem betrifft die Erfindung ungesättigte Fettsäuren sowie Triglyceride mit einem erhöhten Gehalt an ungesättigten Fettsäuren und deren Verwendung.

197 TRANSGENIC ORGANISMS WITH LOWER GROWTH TEMPERATURE PCT/EP2004052492 2004-10-11 WO2005035750A2 2005-04-21 FERRER MANUEL; TIMMIS KENNETH N; CHERNIKOVA TATJANA; GOLYSHIN PETER; YAKIMOV MICHAIL
The present invention in general relates to the growth temperature of organisms, especially plants and microorganisms and the manipulation of the tolerable cultivation temperature. More specifically, the present invention relates to the expression of heterologous proteins in microorganisms, and especially to the heterologous expression of heat sensitive proteins in bacteria, either gram-negative or gram-positive. In a first aspect, the present invention provides a method for manipulation of cells and the resultant cells, characterized in that at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed. Such cells are selected among cultivated eukaryotic cells, i.e. animal and plant cells and entire plants, gram-negative and gram-positive bacteria, fungi and yeasts.
198 PRODUCTION OF A TRANSGENIC AVIAN BY CYTOPLASMIC INJECTION PCT/US2004009253 2004-03-26 WO2004092351A2 2004-10-28 RAPP JEFFREY; CHRISTMANN LEANDRO; HARVEY ALEX; LEAVITT MARKLEY
The invention provides methods for integrating a heterologous polynucleotide into the genome of an avian cell. The methods deliver to an avian cell a polynucleotide and a source of integrase activity that mediates recombination between the polynucleotide and the genomic DNA of the avian cell. The invention provides modified avian or artificial chromosomes as vectors to shuttle transgenes or gene clusters into an avian genome. Another aspect of the invention are avian cells genetically modified with a transgene vector. One cell line for the delivery and integration of a transgene comprises a heterologous attP site and, optionally, a region for expressing the integrase. Methods are also included for the production of a heterologous polypeptide by transgenic avian tissue involve integrating a heterologous polynucleotide into the avian genome. The present invention also relates to methods of producing transgenic chickens which include introducing into an avian cell a nucleic acid comprising a transgene and an integrase activity in addition to a cationic polymer and/or a nuclear localization signal and introducing the avian cell into a recipient avian wherein the recipient avian produces an offspring which includes the transgene. Also included are methods of dispersing a nucleic acid in a cell.
199 METHOD FOR PRODUCING AMINOACIDS PCT/EP0314649 2003-12-19 WO2004057003A3 2004-10-14 SCHMITZ OLIVER; PUZIO PIOTR; BLAU ASTRID; LOOSER RALF; WENDEL BIRGIT; KAMLAGE BEATE; PLESCH GUNNAR
The invention relates to a method for producing aminoacids in transgenic organisms. The inventive method consists of the following steps: a) introduction of nucleic acids sequence which codes threonine decomposing protein or lysine decomposing protein or codes threonine decomposing protein and lysine decomposing protein, b) introduction of nucleic acids sequence which improves the decomposition of threonine or lysine or the decomposition of threonine and lysine in the transgenic organisms; c) expression of (a) or (b) nucleic acids sequence in a transgenic organism. In a very useful manner, the nucleic acids sequence is introduced in the step a) of the method, said sequence being selected from: i) the nucleic acids sequence with the sequence present in SEQ ID NO: 1, SEQ ID NO:11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23 and/or SEQ ID NO:25; ii) the nucleic acids sequence which is preserved as a result of a degenerate genetic code by re-recording aminoacids sequence present in SEQ ID NO: 2, SEQ ID NO: 12, SEQ ID NO:14, SEQ ID NO: 16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24 and/or 26; and iii) a derivative of the nucleic acid sequence present in SEQ ID NO: 1, SEQ ID NO:11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23 and/or SEQ ID NO:25 which codes polypeptides with the nucleic acids sequence present in SEQ ID NO: 2, SEQ ID NO: 12, SEQ ID NO:14, SEQ ID NO: 16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24 and/or 26 and which comprises at least 50 % of homology in terms of aminoacids without reducing the biological activity of polypeptides.
200 METHOD FOR PRODUCING KETOCAROTINOIDS IN GENETICALLY MODIFIED ORGANISMS PCT/EP0309106 2003-08-18 WO2004018694A3 2004-09-10 SAUER MATT; FLACHMANN RALF; KLEBSATTEL MARTIN; SCHOPFER CHRISTEL RENATE
The invention relates to a method for producing ketocarotinoids by cultivating genetically modified organisms having a modified ketolase activity compared to the wild type, to genetically modified organisms, and to the use thereof as foodstuffs and fodder and for producing ketocarotinoid extracts.
QQ群二维码
意见反馈